Atorvastatin Calcium Tablet
Product Images NDC 68071-3546

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3546). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3546 9)

Label for atorvastatin calcium 10 mg tablets by NuCare Pharmaceuticals, Inc., showing a 90-count package. The label includes NDC 68071-3546-9 and instructs users to see the manufacturer's label for a full list of ingredients. It features dosage instructions placeholders, barcodes, and storage conditions at 68-77°F.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 01)

Chemical structure of atorvastatin calcium dihydrate, illustrated as a detailed molecular diagram including calcium ions and water molecules as part of the compound.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 02)

A line graph comparing the cumulative incidence percentage over time (years) between atorvastatin and placebo groups. The graph shows two lines, one solid for atorvastatin and one dashed for placebo, depicting lower cumulative incidence with atorvastatin over approximately 3.5 years.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 03)

A cumulative hazard plot comparing the effects of Atorvastatin and placebo over four years of follow-up. The x-axis represents time to first primary endpoint in years, and the y-axis is cumulative hazard in percentage. Atorvastatin shows a lower cumulative hazard compared to placebo, with hazard ratio and statistical significance indicated.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 04)

A line graph comparing the percentage of subjects experiencing an event over time for atorvastatin 10 mg and 80 mg. The x-axis represents time to the first major cardiovascular endpoint in years, and the y-axis represents the percentage of subjects experiencing the event. Two lines indicate different dosages of atorvastatin with corresponding hazard ratio and p-value noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.